Muscle & Nerve · 2010 · 39 citations · 52 references
MedicineCell BiologyMotor DevelopmentMusculoskeletal RehabilitationNeuromuscular DisordersAntifibrotic TherapyFibrosisMuscle DisordersMuscle PathologyMuscle PhysiologyMuscle TissueFibrosis InhibitionMuscle Fiber IntegrityMusculoskeletal Histopathology
In muscular dystrophies (MD) the loss of muscle and its ability to function are associated with fibrosis. We evaluated the efficacy of halofuginone in reducing fibrosis in the dy(2J)/dy(2J) mouse model of congenital MD. Mice were injected intraperitoneally with 5 microg of halofuginone 3 times a week for 5 or 15 weeks, starting at the age of 3 weeks. Halofuginone caused a reduction in collagen synthesis in hindlimb muscles. This was associated with reductions in the degenerated area, in cell proliferation, in the number of myofibers with central nuclei, with increased myofiber diameter, and with enhanced motor coordination and balance. Halofuginone caused a reduction in infiltrating fibroblasts that were located close to centrally nucleated myofibers. Our results suggest that halofuginone reduced the deleterious effects of fibrosis, thus improving muscle integrity. Halofuginone meets the criteria for a novel antifibrotic therapy for MD patients.
52
Pax7 Is Required for the Specification of Myogenic Satellite Cells
Patrick Seale, Luc A. Sabourin, Adele Girgis-Gabardo et al. · Cell · 2000 · 2.3K citations · Full text
Muscle satellite cells adopt divergent fates
Peter S. Zammit, Jon P. Golding, Yosuke Nagata et al. · The Journal of Cell Biology · 2004 · 897 citations · Full text
Orna Halevy, Y. Piestun, Mohammed Z. Allouh et al. · Developmental Dynamics · 2004 · 327 citations · Full text